Market Tracker

06/27 5:16pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

30.30
Delayed Data
As of 4:00pm ET
 -1.13 / -3.60%
Today’s Change
16.64
Today|||52-Week Range
51.99
-15.01%
Year-to-Date

Today’s Trading

Previous close31.43
Today’s open31.03
Day’s range29.45 - 31.63
Volume2,788,478
Average volume (3 months)3,184,112
Market cap$3.6B
Dividend yield--
Data as of 4:00pm ET, 06/27/2016

Growth & Valuation

Earnings growth (last year)-71.58%
Earnings growth (this year)-9.20%
Earnings growth (next 5 years)+18.27%
Revenue growth (last year)-49.17%
P/E ratioNM
Price/Sales58,810.80
Price/Book16.04

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...-12.25-8.57%
NBIXNeurocrine Bioscienc...-1.49-3.44%
AKRXAkorn Inc-1.40-5.04%
ENDPEndo International P...-1.16-7.81%
Data as of 4:00pm ET, 06/27/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$61.0K
Annual profit (last year)-$164.4M
Net profit margin-269,578.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts